On Feb 1, 2022 Biofidelity closed a Series A round and raised $23,000,000 from Octopus Ventures, SBI Investment, featuring lead investors Octopus Ventures. About the […]
Post-IPO Debt – Centogene
On Feb 1, 2022 Centogene closed a Post-IPO Debt round and raised $45,000,000 from Oxford Finance LLC, featuring lead investors Oxford Finance LLC. About the […]
Post-IPO Equity – Centogene
On Feb 1, 2022 Centogene closed a Post-IPO Equity round and raised €15,000,000 from Careventures, DPE Deutsche Private Equity, TVM Capital Life Science, featuring lead […]
Seed Round – ReviR Therapeutics
On Jan 17, 2022 ReviR Therapeutics closed a Seed round and raised $20,000,000 from 5Y Capital, CDH Investments, Shunwei Capital, Sky9 Capital, Tiantu Capital, featuring […]
Series B – SalioGen Therapeutics
On Jan 5, 2022 SalioGen Therapeutics closed a Series B round and raised $115,000,000 from Cystic Fibrosis Foundation, D1 Capital Partners, EPIQ Capital Group, Fidelity […]
Post-IPO Equity – VBL THERAPEUTICS
On Dec 20, 2021 VBL THERAPEUTICS closed a Post-IPO Equity round and raised €15,000,000 from European Innovation Council, featuring lead investors European Innovation Council. About […]
Grant – VBL THERAPEUTICS
On Dec 20, 2021 VBL THERAPEUTICS closed a Grant round and raised €2,500,000 from European Innovation Council, featuring lead investors European Innovation Council. About the […]
Grant – VBL THERAPEUTICS
On Dec 20, 2021 VBL THERAPEUTICS closed a Grant round and raised €2,500,000 from European Innovation Council, featuring lead investors European Innovation Council. About the […]
Equity Crowdfunding – Future Planet Capital
On Nov 28, 2021 Future Planet Capital closed a Equity Crowdfunding round and raised £2,783,565 from investors, featuring lead investors . About the company: Future […]
Dicerna Pharmaceuticals acquired by Novo Nordisk
Nov 18, 2021 Novo Nordisk has entered into an agreement to acquire Dicerna Pharmaceuticals in a $3,300,000,000 deal. Novo Nordisk based at Bagsværd, Hovedstaden, Denmark. […]
